Nu Skin-NUS Stock Trading Below 200 & 50-Day SMA: What Should You Do Now?

Core Viewpoint - Nu Skin Enterprises, Inc. is experiencing significant challenges, reflected in its stock performance and financial outlook, primarily due to macroeconomic pressures and industry-specific issues [1][3][7]. Financial Performance - Nu Skin's stock has declined 34.5% over the past three months, underperforming the industry decline of 13.8% and the Consumer Staples sector's increase of 6.7% [2]. - In Q2 2024, Nu Skin's revenues fell 12.2% year over year to $439.1 million, with a constant-currency decline of 8% [3]. - The number of sales leaders decreased by 16% year over year to 38,592, while the customer base dropped 14% to 893,514 [3]. - Paid affiliates decreased by 17% to 155,486, with an adjusted decline of 9% [3]. Guidance and Projections - For 2024, Nu Skin revised its revenue guidance to a range of$ 1.73- $1.81 billion, indicating a decline of 12-8% from the previous year [4]. - Adjusted earnings per share (EPS) are projected to be between 75-95 cents, down from$ 1.85 in 2023 [4]. - For Q3 2024, the company expects revenues between $430 million and$ 465 million, suggesting a decline of 14% to 7% from the previous year [5]. Analyst Sentiment - Over the past 60 days, the Zacks Consensus Estimate for the current fiscal year EPS has decreased by 29.1% to 78 cents per share, reflecting negative analyst sentiment [6]. - The estimate for the next fiscal year EPS has also declined by 26.6% to $1.05, indicating ongoing challenges in achieving profitability [6].